Trial Profile
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Bromfenac
- Indications Perioperative pain
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Dec 2009 New trial record.